首页 | 本学科首页   官方微博 | 高级检索  
     

缬沙坦对糖尿病肾病大鼠肾小管上皮细胞整合素连接激酶表达的影响
引用本文:刘纪实,宁建平,张浩,欧阳春. 缬沙坦对糖尿病肾病大鼠肾小管上皮细胞整合素连接激酶表达的影响[J]. 中国中西医结合肾病杂志, 2007, 8(10): 572-575
作者姓名:刘纪实  宁建平  张浩  欧阳春
作者单位:1. 中南大学湘雅三医院肾内科,长沙,410013
2. 中南大学湘雅医院肾内科,长沙,410003
摘    要:目的:观察缬沙坦对糖尿病肾病(DN)大鼠肾小管上皮细胞整合素连接激酶(ILK)表达的影响,探讨缬沙坦肾脏保护作用的可能机制。方法:30只Wistar雄性大鼠随机分为正常组(n=10)、模型组(n=10)和干预组(缬沙坦30mg·kg^-1·d^-1,n=10)。第8、16周每组各处死5只大鼠,观察大鼠肾脏病理改变以及免疫组化方法检测其肾小管上皮细胞转化生长因子-β1(TGF-β1)、ILK的表达并作半定量分析。结果:(1)DN大鼠肾小管上皮细胞ILK与TGF-β1同向表达增高,随病程进展递增;(2)缬沙坦干预后大鼠肾小管上皮细胞ILK表达较模型组显著降低。结论:(1)DN大鼠肾小管上皮细胞ILK与TGF-β1同向表达增高,提示ILK是肾间质纤维化发展的一个重要因素;(2)缬沙坦可能通过下调ILK来改善肾间质纤维化病变而发挥肾脏保护作用。

关 键 词:糖尿病肾病  整合素连接激酶  缬沙坦  转化生长因子-β1
修稿时间:2006-11-27

Effects of Valsartan on Expression of ILK in Renal Tubular Epithelial Cells of Diabetic Nephropathy Rats
LIU dishi , NING dianping , ZHANG Hao , et al. Effects of Valsartan on Expression of ILK in Renal Tubular Epithelial Cells of Diabetic Nephropathy Rats[J]. Chinese Journal of Integrated Traditional and Western Nephrology, 2007, 8(10): 572-575
Authors:LIU dishi    NING dianping    ZHANG Hao    et al
Abstract:Objective:To observe the effects of valsartan on expression of integrin- linked kinase(ILK)in renal tubular epithelial cells of diabetic nephropathy rats, eucidate the possible renal - protective mechanisms of valsartan. Methods:Thirty male wistar rats were randomly divided into 3 groups: normal control group ( n = 10), diabetic model group ( n = 10), and valsartan treatment group (valsartan 30 mg·kg^-1·d^-1, n = 10). Five rats of each group were killed respectively at 8, 16 weeks. The pathology change and expressions of transforming growth factor (TGF -β1 ) and ILK in renal tubular epithelial cells were detected. Results: ( 1 )Expressions of TGF-β1 and ILK in renal tubular epithelial cells increased in the diabetic model group in a time - dependent manner. (2) ILK expression in valsartan treatment group was significant lower than in diabetic model rats. Conclusion. (1)ILK expression level in renal tubular epithelial cells of diabetic rats is high, which indicates ILK may be an important factor in the progress of renal interstitial fibrosis in diabetic nephropathy. (2)Valsartan can improve the process of renal tubularinterstitial fibrosis by downregulate the ILK expression.
Keywords:Diabetic nephropathy Integrin- linked kinase(ILK) Valsartan TGF-β1
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号